LC-MS/MS-based clinical value exploration of the methionine cycle in luminal breast cancer
Abstract
A group of patients with luminal breast cancer progresses to advanced stages because of endocrine therapy failure. While palbociclib improves the disease prognosis in the clinic, resistance after treatment remains a prominent issue. As a core systemic metabolic component, the methionine cycle currently lacks systematic research on luminal breast cancer and palbociclib resistance. The present study enrolled 146 patients with luminal breast cancer and 36 HCs from Jiangsu Cancer Hospital (Nanjing, China). Liquid chromatography-tandem mass spectrometry was used to detect the methionine cycle-related metabolites in the plasma. The Mann-Whitney U test was used to compare intergroup differences and diagnostic efficacy was evaluated using receiver operating characteristic curve analysis. Least absolute shrinkage and selection operator was applied to screen resistance-related variables, after which a nomogram prediction model was constructed. Plasma levels of methionine, S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH) and homocysteine were lower in patients with luminal breast cancer when compared with HCs, with an AUC of 0.8130 for the combined metabolites in diagnosis. Late-stage patients had lower methionine, SAM, SAH, as well as the SAM/SAH ratio than early-stage patients, with combined metabolites achieving an AUC of 0.9228. Additionally, palbociclib-resistant patients had lower SAM, SAH and homocysteine levels, with combined metabolites showing an AUC of 0.9229 for…
Read the paper
Related studies
- Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
- Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
- Antioxidants, inflammation and cardiovascular disease
- Application of Metabolomics in Alzheimer’s Disease
- Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review
- Nutritional essentiality of sulfur in health and disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.